Tiotropium BromideThird Party Manufacturing in India

Tiotropium Bromide works by competitively and reversibly inhibiting muscarinic receptors in the bronchial smooth musculature, with high affinity for M3 receptors. It inhibits these targets to help the body counteract acetylcholine-induced bronchoconstriction, promoting prolonged relaxation of the airways. Unlike short-acting bronchodilators, it dissociates very slowly from M3 receptors, offering a sustained 24-hour therapeutic effect from a single dose. It is highly effective and well-tolerated for chronic respiratory maintenance.

Therapeutic Uses

• COPD Management: Functions as a long-term maintenance treatment to control airflow limitation in chronic bronchitis and emphysema.
• Asthma Maintenance: Acts as an add-on bronchodilator therapy for adults experiencing severe, persistent asthma symptoms.
• Exacerbation Reduction: Lowers the frequency and severity of acute respiratory distress flare-ups in susceptible patients.
• Dyspnea Relief: Improves daily exercise tolerance by significantly reducing breathing difficulties.

Why Manufacturers Choose Tiotropium Bromide

Tiotropium Bromide third party manufacturing in India is highly specialized because dry powder inhalation chemistry requires advanced micro-particle micronization. Our partner facilities deploy cleanroom environments and dedicated capsule-filling lines engineered precisely for inhalation powders. Every batch aligns with WHO-GMP protocols, ensuring strict aerodynamic particle size distribution and uniform dosing that meets rigorous global export standards.